Cargando…
Steven-Johnson Syndrome: A Rare but Serious Adverse Event of Nivolumab Use in a Patient With Metastatic Gastric Adenocarcinoma
Nivolumab is a humanized monoclonal anti-programmed cell death receptor-1 (PD-1) antibody that has been authorized for use in the treatment of advanced malignancies. Cutaneous reactions are the most common immune-related adverse events reported with anti-PD-1 agents, and they range broadly from mild...
Autores principales: | Saad, Eltaib, Adhikari, Pabitra, Antala, Drashti, Abdulrahman, Ahmed, Begiashvili, Valiko, Mohamed, Khalid, Ali, Elrazi, Zhang, Qishou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534193/ https://www.ncbi.nlm.nih.gov/pubmed/36258702 http://dx.doi.org/10.14740/jmc3992 |
Ejemplares similares
-
Pericardial Metastasis From Recurrent Squamous Cell Carcinoma of Hypopharynx in a Living Patient
por: Antala, Drashti, et al.
Publicado: (2022) -
Stevens-Johnson Syndrome
por: Laun, Jake, et al.
Publicado: (2016) -
Stevens-Johnson Syndrome and Stroke Related to Mycoplasma
por: Yadava, Sanjay K., et al.
Publicado: (2022) -
Stevens Johnson Syndrome Initiated by an Adverse Reaction to Trimethoprim-Sulfamethoxazole
por: Buganu, Adelina, et al.
Publicado: (2020) -
Docetaxel-Induced Stevens-Johnson Syndrome in a Patient with Metastatic Prostate Adenocarcinoma
por: Diab, Osama, et al.
Publicado: (2019)